Skip to content
Open access

A DNM1L GTPase Effector Domain Deletion Causes Intermediate Defects in Peroxisomal and Mitochondrial Dynamics and Reveals a Targetable Metabolic Vulnerability

Nov 2026 · bioRxiv · 0 citations
Biology

TL;DR

Findings support a functional allelic spectrum in DNM1L-associated disease in which protein domain contributes to, but does not completely determine, functional severity.

Abstract

DNM1L encodes dynamin-related protein 1 (DRP1), a key GTPase regulating mitochondrial and peroxisomal dynamics. Pathogenic DNM1L variants are associated with a broad spectrum of neurodevelopmental and neurodegenerative disorders, with phenotypic severity varying by affected protein domain. While variants in the GTPase domain are typically associated with milder phenotypes and middle-domain variants with severe developmental and epileptic encephalopathy, the functional impact of GTPase effector domain (GED) variants remains less defined. Here, we describe four individuals harboring a recurrent heterozygous GED deletion (L700del) presenting with movement disorders and lacking severe infantile encephalopathy, consistent with an intermediate clinical phenotype. Patient-derived fibroblasts exhibited tubular peroxisomes and enlarged mitochondria, while Drosophila models demonstrated that DNM1LL700del has intermediate functional effects that were more pronounced than those of a GTPase-domain variant A192E but less severe than those of the middle-domain variant G350R. Comparison with another GED variant, Y691C, further demonstrated variant-specific differences in severity within the GED. Metabolic stress assays showed that L700del fibroblasts exhibited impaired growth under galactose conditions, consistent with increased vulnerability under conditions dependent on mitochondrial oxidative metabolism. Bezafibrate, a PPAR agonist that promotes mitochondrial biogenesis, partially rescued this growth defect. Together, these findings support a functional allelic spectrum in DNM1L-associated disease in which protein domain contributes to, but does not completely determine, functional severity. L700del represents an intermediate-strength allele associated with a movement-disorder phenotype and a pharmacologically modifiable metabolic vulnerability.

Read PDF

Similar papers

Review Open access Sep 2026

A De Novo Gain-of-Function Variant of DNM1L Causes Developmental Encephalopathy.

BACKGROUND Variants in the dynamin 1-like (DNM1L) gene, which encodes dynamin-related protein 1 (Drp1), can cause encephalopathy due to defective mitochondrial and peroxisomal fission 1 (EMPF1) and optic atrophy 5 (OPA5), two neurodevelopmental disorders with distinct symptoms. Given the critical role of Drp1 in mitoch...

Shang-Sheng Dong, Yan-Juan Chen, Meng-Fang Yan et al. · 0 citations
Open access Sep 2026

A novel de novo DNM1L mutation linked to mitochondrial fission dysfunction in a pediatric patient with epileptic encephalopathy and refractory seizures

Mitochondrial dynamics are essential for neuronal function, with dynamin-related protein 1 (DRP1), encoded by the DNM1L gene, playing a key role in mitochondrial fission. Pathogenic variants in DNM1L are associated with a spectrum of severe neurodevelopmental and neurodegenerative disorders. This study aime...

M. J. Herrero-Turrión, A. Hernández-Fabián, R. Gómez-Nieto et al. · 0 citations
Open access Oct 2026

RMND1 dysfunction causes OXPHOS deficiency and alters mitoribosomal protein homeostasis in vivo.

Pathogenic, bi-allelic variants in RMND1 typically manifest as an early-onset multisystemic mitochondrial disease, yet the consequences of RMND1 dysfunction in vivo remain poorly understood. To answer this question, we generated and characterized the first in vivo model of RMND1-related disease, carrying the recurrent...

Alba Pesini, M. Sánchez-Quintero, C. López-Gómez et al. · 0 citations
Oct 2026

A novel NDUFS1 missense variant associated with optic atrophy and mitochondrial dysfunction.

Two compound heterozygous variants in the NDUFS1 gene in a patient presenting with optic atrophy are identified including the known variant c.64C>T p.(R22X) and a novel variant c.404G>A p.(G135D), associated with impaired complex I-mediated electron transfer and mitochondrial dysfunction, providing insights into the pa...

Zhen-Hui Liu, Yu-Jie Jin, Yan Li et al. · 0 citations
Open access Sep 2026

Pathogenic mutations in ATAD3A cause dysregulation of RagC/D-TFEB axis and disrupt lysosomal homeostasis

A novel role for the mitochondrial resident protein ATAD3A is revealed in modulating lysosomal homeostasis through regulation of the mTORC1-TFEB axis, providing a mechanistic link between impaired mitochondrial and lysosomal homeostasis in a neurodevelopmental disorder.

Matthew B. McDougal, Abigail Sandoval, M. Kinter et al. · 0 citations
Open access Oct 2026

Bi-allelic variants in the secretory pathway gene SEC16A are associated with a neurodevelopmental disorder.

SEC16A encodes a scaffold protein that organizes the endoplasmic reticulum (ER) exit sites, specialized ER subdomains that mediate export of newly synthesized proteins and regulate early secretory pathway steps. The role of SEC16A in human nervous system diseases has not been established yet. Here, we report six indivi...

Meng-Qi Ma, Xiao-Wei Lei, Juan Li et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.